Ocular venous occlusion in pediatrics: Should thrombophilia investigation and anticoagulant treatment be initiated?

Marganit Benish, Shai Shrot, Assaf Barg, Iris Kventsel, Ronit Elhasid, Gili Kenet, Sarina Levy-Mendelovich*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Retinal vein occlusion (RVO) and superior ophthalmic vein thrombosis (SOVT) are rare diseases in the pediatric population; however, the ophthalmic and neurologic morbidity are significant. As published data are scarce for these conditions, we present our experience with pediatric ocular venous thrombosis in four patients, and discuss recommended management for evaluation and treatment. We suggest performing thrombophilia workup for all pediatric patients with RVO or SOVT. In patients with thrombophilia risk factors or patients with additional thrombi, we highly recommend initiating anticoagulation therapy. There is a need for more research in order to determine the optimal management strategy.

Original languageEnglish
Article numbere30689
JournalPediatric Blood and Cancer
Volume70
Issue number12
DOIs
StatePublished - Dec 2023

Keywords

  • anticoagulation
  • ocular venous thrombosis
  • thrombophilia

Fingerprint

Dive into the research topics of 'Ocular venous occlusion in pediatrics: Should thrombophilia investigation and anticoagulant treatment be initiated?'. Together they form a unique fingerprint.

Cite this